Welcome to a new episode, where we explore the forefront of longevity medicine and regenerative health. Our guests are Dr. Metin Kurtoglu, M.D., Ph.D., and Estelle Nordenfalk, CEO of AgeBack.co.

Dr. Kurtoglu is a third-generation physician whose journey spans from early medical studies to advanced research in the U.S. After training in internal medicine at Jackson Memorial Health and the University of Miami, and pursuing oncology research at the National Institutes of Health, he went on to lead cutting-edge developments at Cartesian - including the world’s first RNA-transfected CAR-T cell therapy for autoimmune disorders, now in an international phase 3 trial.

At AgeBack.co in Stockholm, Dr. Metin provides a comprehensive overview of modern longevity protocols and how new technologies and regenerative treatments are being used to optimize recovery, performance, and long-term vitality. A special focus is placed on Hyperbaric Oxygen Therapy (HBOT) - a central component of the AgeBack model - alongside advanced regenerative therapies such as stem cells, exosomes, and plasma exchange.

Estelle Nordenfalk, CEO of AgeBack.co, leads this innovative longevity clinic offering personalized programs rooted in diagnostics, precision medicine, and cellular science - bridging expertise between Stockholm and their advanced partner clinic in Istanbul.

Together, we’ll dive into how modern science is transforming the way we approach aging, healing, and human potential.

♥ Facebook: https://www.facebook.com/integrativmedicin

♥ Instagram: https://www.instagram.com/both_instead_of_either_or

♥ Youtube: https://www.youtube.com/user/integrativMedicin